Results of a randomized double-blind multicenter clinical trial of the efficacy and safety of the drug riamilovir for the prevention of COVID-19
Aim. Evaluation of the efficacy and safety of riamilovir as a drug for the prevention of coronavirus infection (COVID-19) in adults who have constant contact with COVID-19 patients as a result of living together. Materials and methods. The study included 750 adult participants living with patient...
محفوظ في:
| المؤلفون الرئيسيون: | , , , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Russo |
| منشور في: |
"Consilium Medicum" Publishing house
2024-04-01
|
| سلاسل: | Терапевтический архив |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://ter-arkhiv.ru/0040-3660/article/viewFile/630409/145850 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|